Read More Healthcare Industry News Bexson Biomedical raises $4.8m to advance wearable ketamine treatment for pain and mental health disorders Bexson Biomedical has successfully raised $4.8 million in Series A funding to accelerate the development of its subcutaneous… bypharmanewsdailyFebruary 3, 2021
